The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hoberman Kenneth since 2013.
This trader's CIK number is 1573722.
At the time of last reporting, Hoberman Kenneth was the Officer of Nuvectis Pharma, Inc.. (stock ticker symbol NVCT).
Also see all insider trading activities at Nuvectis Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NVCT | 6,000 | $104,399 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | STML | 0 | $0 | 119,417 | $998,886 | 0 | $0 |
| 2019 | STML | 0 | $0 | 126,113 | $1,666,941 | 0 | $0 |
| 2018 | STML | 0 | $0 | 86,227 | $1,298,173 | 0 | $0 |
| 2017 | STML | 0 | $0 | 32,970 | $380,741 | 0 | $0 |
| 2016 | STML | 0 | $0 | 3,915 | $19,703 | 0 | $0 |
| 2015 | STML | 0 | $0 | 18,900 | $306,687 | 27,105 | $110,859 |
| 2014 | STML | 2,000 | $21,976 | 15,250 | $203,130 | 0 | $0 |
| 2013 | STML | 0 | $0 | 44,428 | $920,617 | 112,940 | $125,363 |
1. Nuvectis Pharma, Inc. (NVCT)
2. Stemline Therapeutics Inc (STML)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-12 | NVCT | Buy | 6,000 | 17.40 | 104,399 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-09 | STML | Sale | 9,487 | 5.08 | 48,193 |
| 2020-03-10 | STML | Sale | 16,704 | 4.91 | 82,016 |
| 2020-02-25 | STML | Sale | 11,547 | 6.42 | 74,131 |
| 2020-01-22 | STML | Sale | 22,139 | 7.02 | 155,415 |
| 2020-01-08 | STML | Sale | 13,228 | 10.37 | 137,174 |
| 2019-12-23 | STML | Sale | 4,319 | 10.58 | 45,695 |
| 2019-12-24 | STML | Sale | 24,477 | 10.97 | 268,512 |
| 2019-12-26 | STML | Sale | 15,494 | 10.75 | 166,560 |
| 2019-12-27 | STML | Sale | 2,022 | 10.48 | 21,190 |
| 2019-06-25 | STML | Sale | 25,500 | 15.07 | 384,285 |
| 2019-06-24 | STML | Sale | 9,107 | 15.49 | 141,067 |
| 2019-06-26 | STML | Sale | 12,508 | 14.77 | 184,743 |
| 2019-05-14 | STML | Sale | 25,817 | 14.27 | 368,408 |
| 2019-03-12 | STML | Sale | 981 | 11.04 | 10,830 |
| 2019-03-11 | STML | Sale | 25,101 | 11.11 | 278,872 |
| 2019-03-07 | STML | Sale | 2,995 | 11.36 | 34,023 |
| 2019-02-25 | STML | Sale | 10,557 | 12.05 | 127,211 |
| 2019-01-08 | STML | Sale | 13,547 | 10.15 | 137,502 |
| 2018-11-26 | STML | Sale | 26,296 | 11.85 | 311,607 |
| 2018-03-12 | STML | Sale | 17,241 | 17.71 | 305,338 |
| 2018-03-13 | STML | Sale | 12,746 | 16.82 | 214,387 |
| 2018-03-07 | STML | Sale | 3,027 | 16.55 | 50,096 |
| 2018-02-26 | STML | Sale | 5,300 | 17.61 | 93,333 |
| 2018-02-27 | STML | Sale | 5,726 | 17.26 | 98,830 |
| 2018-02-15 | STML | Sale | 1,851 | 15.67 | 29,005 |
| 2018-01-08 | STML | Sale | 14,040 | 13.93 | 195,577 |
| 2017-12-15 | STML | Sale | 11,943 | 14.18 | 169,351 |
| 2017-12-18 | STML | Sale | 40 | 14.75 | 590 |
| 2017-03-07 | STML | Sale | 2,342 | 8.16 | 19,110 |
| 2017-02-28 | STML | Sale | 4,027 | 7.01 | 28,229 |
| 2017-02-27 | STML | Sale | 4,000 | 6.97 | 27,880 |
| 2017-02-16 | STML | Sale | 1,508 | 6.42 | 9,681 |
| 2017-01-10 | STML | Sale | 9,110 | 13.82 | 125,900 |
| 2016-03-08 | STML | Sale | 2,412 | 5.34 | 12,880 |
| 2016-02-17 | STML | Sale | 1,503 | 4.54 | 6,823 |
| 2015-03-19 | STML | Sale | 17,307 | 16.43 | 284,354 |
| 2015-03-19 | STML | Option Ex | 27,105 | 4.09 | 110,859 |
| 2015-02-18 | STML | Sale | 1,593 | 14.02 | 22,333 |
| 2014-09-02 | STML | Buy | 2,000 | 10.99 | 21,976 |
| 2014-05-21 | STML | Sale | 15,250 | 13.32 | 203,130 |
| 2013-11-26 | STML | Sale | 3,144 | 21.27 | 66,872 |
| 2013-11-27 | STML | Option Ex | 33,973 | 1.11 | 37,710 |
| 2013-11-25 | STML | Sale | 14,350 | 21.94 | 314,839 |
| 2013-11-26 | STML | Option Ex | 6,967 | 1.11 | 7,733 |
| 2013-11-25 | STML | Option Ex | 37,000 | 1.11 | 41,070 |
| 2013-11-22 | STML | Sale | 11,523 | 20.14 | 232,073 |
| 2013-11-22 | STML | Option Ex | 35,000 | 1.11 | 38,850 |
| 2013-11-27 | STML | Sale | 15,411 | 19.91 | 306,833 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoberman Kenneth (Officer of Nuvectis Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.